A listing of affective-disorders-program medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
In this study, the aim is to assess the efficacy after one and two administrations of COMP360 25 mg or COMP360 10 mg versus COMP360 1 mg for reducing symptom severity in TRD, when administered with psychological support.
The goal of this study is to further our understanding of the relationship between depression and hypersomnia by examining mood-relevant domains of slow wave sleep and reward function.
This is an international, multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study in patients with a primary diagnosis of MDD to evaluate the efficacy of lumateperone 42 mg administered once daily compared with placebo as adjunctive treatment to antidepressant therapy